Comparison of Mitoxantrone in Combination with Intermediate-dose Cytarabine versus High-dose Cytarabine as Consolidation Therapies for Young Non-APL Acute Myeloid Leukemia Patients with Favorable and Intermediate Cytogenetics
Crossref DOI link: https://doi.org/10.1007/s11596-018-1845-x
Published Online: 2018-03-15
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Ji-hao
Lin, Hai-qing
Shen, Qi
Hu, Li-na
Li, Guo-qiang
Sun, Xiong-fei
Zhang, Xin-you
Text and Data Mining valid from 2018-02-01
Article History
Received: 25 February 2017
Revised: 7 July 2017
First Online: 15 March 2018